273 related articles for article (PubMed ID: 34766253)
1. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.
Wu R; Li JX
CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253
[TBL] [Abstract][Full Text] [Related]
2. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists.
Kleinau G; Pratzka J; Nürnberg D; Grüters A; Führer-Sakel D; Krude H; Köhrle J; Schöneberg T; Biebermann H
PLoS One; 2011; 6(10):e27073. PubMed ID: 22073124
[TBL] [Abstract][Full Text] [Related]
4. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
Revel FG; Moreau JL; Gainetdinov RR; Bradaia A; Sotnikova TD; Mory R; Durkin S; Zbinden KG; Norcross R; Meyer CA; Metzler V; Chaboz S; Ozmen L; Trube G; Pouzet B; Bettler B; Caron MG; Wettstein JG; Hoener MC
Proc Natl Acad Sci U S A; 2011 May; 108(20):8485-90. PubMed ID: 21525407
[TBL] [Abstract][Full Text] [Related]
5. Further insights into the pharmacology of the human trace amine-associated receptors: discovery of novel ligands for TAAR1 by a virtual screening approach.
Cichero E; Espinoza S; Franchini S; Guariento S; Brasili L; Gainetdinov RR; Fossa P
Chem Biol Drug Des; 2014 Dec; 84(6):712-20. PubMed ID: 24894156
[TBL] [Abstract][Full Text] [Related]
6. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics.
Revel FG; Moreau JL; Gainetdinov RR; Ferragud A; Velázquez-Sánchez C; Sotnikova TD; Morairty SR; Harmeier A; Groebke Zbinden K; Norcross RD; Bradaia A; Kilduff TS; Biemans B; Pouzet B; Caron MG; Canales JJ; Wallace TL; Wettstein JG; Hoener MC
Biol Psychiatry; 2012 Dec; 72(11):934-42. PubMed ID: 22705041
[TBL] [Abstract][Full Text] [Related]
7. TAAR1 as an emerging target for the treatment of psychiatric disorders.
Liu J; Wu R; Li JX
Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862
[TBL] [Abstract][Full Text] [Related]
8. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
9. Recognition of methamphetamine and other amines by trace amine receptor TAAR1.
Liu H; Zheng Y; Wang Y; Wang Y; He X; Xu P; Huang S; Yuan Q; Zhang X; Wang L; Jiang K; Chen H; Li Z; Liu W; Wang S; Xu HE; Xu F
Nature; 2023 Dec; 624(7992):663-671. PubMed ID: 37935377
[TBL] [Abstract][Full Text] [Related]
10. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
[TBL] [Abstract][Full Text] [Related]
11. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.
Leo D; Targa G; Espinoza S; Villers A; Gainetdinov RR; Ris L
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887159
[TBL] [Abstract][Full Text] [Related]
12. Trace amine-associated receptor 1 and drug abuse.
Wu R; Liu J; Li JX
Adv Pharmacol; 2022; 93():373-401. PubMed ID: 35341572
[TBL] [Abstract][Full Text] [Related]
13. Selective TAAR1 agonists induce conditioned taste aversion.
Liu J; Wu R; Johnson B; Zhang Y; Zhu Q; Li JX
Psychopharmacology (Berl); 2022 Oct; 239(10):3345-3353. PubMed ID: 36056214
[TBL] [Abstract][Full Text] [Related]
14. Trace amine-associated receptor 1 as a monoaminergic modulator in brain.
Xie Z; Miller GM
Biochem Pharmacol; 2009 Nov; 78(9):1095-104. PubMed ID: 19482011
[TBL] [Abstract][Full Text] [Related]
15. Vasodilator Effect of Trace Amines, 3-Iodothyronamine, and RO5263397 in the Rat Perfused Kidney: Comparison with Tryptamine.
Jragh D; Chandrasekhar B; Yousif MHM; Oriowo MA
Pharmacology; 2023; 108(4):368-378. PubMed ID: 37245501
[TBL] [Abstract][Full Text] [Related]
16. Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.
Hu LA; Zhou T; Ahn J; Wang S; Zhou J; Hu Y; Liu Q
Biochem J; 2009 Oct; 424(1):39-45. PubMed ID: 19725810
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1.
Wainscott DB; Little SP; Yin T; Tu Y; Rocco VP; He JX; Nelson DL
J Pharmacol Exp Ther; 2007 Jan; 320(1):475-85. PubMed ID: 17038507
[TBL] [Abstract][Full Text] [Related]
18. Trace amine-associated receptors and their ligands.
Zucchi R; Chiellini G; Scanlan TS; Grandy DK
Br J Pharmacol; 2006 Dec; 149(8):967-78. PubMed ID: 17088868
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute and chronic administration of trace amine-associated receptor 1 (TAAR1) ligands on in vivo excitability of central monoamine-secreting neurons in rats.
Grinchii D; Hoener MC; Khoury T; Dekhtiarenko R; Nejati Bervanlou R; Jezova D; Dremencov E
Mol Psychiatry; 2022 Dec; 27(12):4861-4868. PubMed ID: 36045279
[TBL] [Abstract][Full Text] [Related]
20. Trace Amines and Their Receptors.
Gainetdinov RR; Hoener MC; Berry MD
Pharmacol Rev; 2018 Jul; 70(3):549-620. PubMed ID: 29941461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
